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Introduction
Surgical resection remains the mainstay treatment for
patients with localized esophageal cancer. It is justified
only when acceptably low morbidity and mortality rates can
be achieved; otherwise, the benefits gained by those who
survive the operation are offset by the deaths of others.1 A
volume–outcome relationship is evident in complex surgery
like esophagectomy; in dedicated high-volume centers,
resection mortality rate of 2–3% can be achieved.2–8 It is
also true that the overall mortality rate still approximates
10% when results from multicenter trials and national
figures are included.9,10 It is thus important to appraise the
factors leading to such diverse results, and seek ways to
improve this.
The outcome of esophagectomy is mainly related to: (1)
selecting appropriate patients for resection and optimizing
the patients’ physiologic status before surgery, (2) choice of
surgical techniques and their execution, and (3) perioper-
ative care.
Risk Assessment and Patient Selection
for Esophagectomy
Assessing a patient’s fitness is often based on the surgeons’
experience and intuition rather than an exact science.
Objective scores have been developed to aid this process
using various statistical methods.11,12 Using a composite
score compromising general status, poor cardiac, hepatic,
and respiratory function as independent predictors of
postoperative death, one group of investigators reduced
postoperative mortality rate from 9.4% to 1.6%.3,12 It is
uncertain if patient selection based on a “strict” mathematical
scoring system is better than that of surgeons and anesthesi-
ologists’ assessments alone. They are more likely to be
complimentary to each other. When patients with squamous
cell cancers and adenocarcinomas are compared, they may
have different risk profiles, in part related to their dissimilar
etiological factors. The main risks for the former group seem
to be pulmonary and hepatic, related to smoking and alcohol
consumption, while for the latter, cardiac risk factors may be
more important, associated with obesity.3 The focus of
perioperative care has to be adjusted for these two types of
patients.
Once a patient is selected for surgical resection, optimizing
his or her physiological status should be an important goal of
preoperative preparation. However, what one could achieve is
usually limited. Patients with impaired liver reserve related to
chronic alcoholism or hepatitis cannot be made better, and
pulmonary damage from chronic smoking is mostly irrevers-
ible. Patients should still be made to stop smoking and abstain
from alcohol and intensive chest physiotherapy applied.
Patients with reversible airway obstructive disease should
have their bronchodilator therapy optimized. One potentially
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“treatable” adverse factor is cardiac ischemia; when signifi-
cant coronary atherosclerotic stenosis is found, revasculariza-
tion by percutaneous coronary angioplasty is a definite
beneficial therapeutic strategy. Patients with high-grade
esophageal malignant stricture may have lost substantial
amount of their body weight. Providing high caloric and high
protein dietary supplement, even in the form of nasogastric
tube feeding, will improve their general physique in a
relatively short time.
Choice of Surgical Procedure
There are different surgical approaches for esophagectomy,
including the transhiatal approach, esophagectomy via a left
or right thoracotomy, or in recent years, minimally invasive
surgery involving thoracoscopy and/or laparoscopy. There
is also a choice of the organ (stomach, colon, and jejunum)
used to restore intestinal continuity, the route taken to place
the conduit (intrathoracic, orthotopic, retrosternal, or sub-
cutaneous), and the location of the esophageal anastomosis
(neck or chest). The intended extent of lymphadenectomy
plays an important role in this decision-making. When
considering radical lymphadenectomy, the physiological
reserve of the patient has to be taken into account, as such
an operation may not be appropriate in a high-risk patient.13
The various combinations of surgical options have to be
carefully chosen for individual patient.
The debate on whether a transthoracic or a transhiatal
resection is to be used has been ongoing. Proponents of
transhiatal resection believe that surgical resection for
esophageal cancer is mostly palliative, and a cure is a
chance phenomenon for only those with very early tumors.
The operating time is also shorter, and postoperative
morbidity is less. Equivalent survival to transthoracic
resection is claimed.14 Conversely, surgeons who practice
transthoracic esophagectomy consider the open approach to
be safer, with less chance of injury to the tracheo-bronchial
tree, thoracic duct, recurrent laryngeal nerves, azygous
vein, and aorta.15 A more thorough lymphadenectomy leads
to better staging and also longer survival, but at the same
time, extensive lymphadenectomy may lead to more
postoperative complications.
The largest randomized trial comparing the two
approaches to date compared 106 patients who underwent
transhiatal esophagectomy with 114 patients who had the
transthoracic approach for mid-lower third/cardia adeno-
carcinomas. Pulmonary complication rates were 27% in
the former group compared to 57% in the later. Ventilation
time, intensive care, and hospital stay were longer in the
transthoracic group. There were, however, no significant
differences in in-hospital mortality at 2% and 4%.
Significantly more lymph nodes were dissected in the
transthoracic group (16 vs. 31). There was a trend toward
a survival benefit with the transthoracic approach at
5 years: disease-free survival was 27% compared with
39%, overall survival was 29% compared with 39%.
There was also no difference in quality of life in the long
run between both groups.16 A subsequent follow-up study
showed that for Siewert type I tumors (true esophageal), an
estimated survival benefit of 14% (5-year survival 37% vs.
51%) was evident (though statistically insignificant), while
this was absent for type II (true cardia/gastroesophageal
junction) cancers (5-year survival 31% and 27%). In
addition, in patients with limited nodal disease (one to
eight metastatic nodes), a significant survival benefit
existed (5-year survival 23% vs. 64%). This effect was
not found for patients without nodal metastases or in those
with more than eight positive nodes, suggesting that
extended lymphadenectomy provides survival benefits in
patients with limited spread.17 Further convincing evidence
for the benefit of lymphadenectomy is also shown in a
recent international multicenter study involving 2,303
patients from both western and eastern centers, which
demonstrated on multivariate analysis that both the number
of involved nodes as well as the number of nodes removed
at operation were of prognostic significance.18
It does seem that the advent of transhiatal esophagec-
tomy came at a time when esophagectomy was a high-risk
operation with high mortality rates, and this “less invasive”
method probably contributed to reducing overall death
rates. With improvement in surgical techniques and
perioperative care, it seems that in most experienced
centers, when selected appropriately, both procedures can
be carried out safely, and the margin of benefit in reducing
morbidity for most patients with the transhiatal operation is
not overwhelming. There is also increasing evidence of the
benefits of radical lymphadenectomy in recent years. With
these considerations, the transthoracic approach with
radical nodal dissection should be the procedure of choice
in patients with good risk and limited localized disease.
In Asian countries, the transhiatal vs. transthoracic
debate has not been a major controversy. This is because
the type of cancers are mostly advanced tumors of the
middle and upper esophagus. In these patients, from a
purely technical and safety standpoint, the transhiatal
method is much less suitable except in early tumors.
Mediastinal lymph node dissection is also deemed to be
more important, given the more proximally located tumors,
and these stations cannot be reached from the abdomen.
Thus, transthoracic resection remains the surgical approach
of choice.
Minimally invasive surgery (MIS) as applied to esoph-
agectomy, like the transhiatal approach, aims at reducing the
trauma of surgical access further. What is potentially better
than the transhiatal approach is that when a thoracoscopic
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phase is used, a thorough mediastinal nodal dissection can be
performed as well. By reducing the size of the wounds,
cardiopulmonary complications may be further reduced,
without sacrificing the extent of lymphadenectomy. Indeed,
with the magnification offered by thoracoscopy, some inves-
tigators have claimed better and more meticulous nodal
dissection with the MIS approach.19,20
Many different MIS approaches in esophagectomy have
been devised, including various combinations of thoraco-
scopy, laparoscopy, mediastinoscopy, and laparoscopic-
assisted (with minilaparotomy or hand-port devices) or
thoracoscopic-assisted methods (with minithoracotomy). The
myriad of surgical methods implies a lack of consensus on
which is superior.21 The most popular is perhaps thoraco-
scopic esophagectomy with gastric mobilization via a
laparotomy and cervical esophago-gastrostomy.20,22–25 Most
performed the thoracoscopic procedures using a lateral
position, though some also advocated a prone position for
improved exposure, since the lung and blood naturally fall
away from the operating field.25–27
Contraindications for thoracoscopic procedures may
include extensive pleural adhesions and bulky or locally
infiltrative tumors, especially those in close proximity with
the tracheo-bronchial tree. Some surgeons do not recom-
mend the procedure in patients with prior irradiation
because tissue planes may be obscured,28 while others do
not find this prohibitive.23 In many series, early-stage
cancers or patients with high-grade dysplasia were prefer-
entially selected, partly because of the technical ease with
which these tumors can be resected.29,30 In a large series of
222 patients, two thirds of patients had cancer of stage II
and below; 21% had high-grade dysplasia.31
The lack of tactile control is probably a contributory
factor in some intraoperative complications, such as
bleeding from the azygous vein32 and from intercostal
vessel,33 injury to the aorta,34 tracheo-bronchial tree,35,36
and recurrent laryngeal nerve.37 On the contrary, the
increased magnification and excellent visualization offered
by thoracoscopy might in fact help lessen complications.
Less blood loss22 and reduction in transient recurrent
laryngeal nerve palsy from 80% to 18% were reported.38
As surgical techniques mature and instrumentation
improves, the chance of intra-operative mishaps will likely
reduce.
Most published studies include small number of patients,
with the exception of a few which included more than 100
patients.23,25,27,31,39 Direct comparisons of results with
patients who underwent conventional esophagectomy,
either in concurrent or historical cohorts of patients, are
also uncommon. When benefits are found, these included
blood loss, shortened intensive care or hospital stay,
analgesic requirement, spirometric and pulmonary function
derangements,20,40–42 and biochemical changes.43 Some
authors also reported less morbidities, such as less recurrent
laryngeal nerve injury and pulmonary38 and cardiac
complications,35,44 but certainly these advantages are not
universally accepted.39 Short- to medium-term quality-of-
life scores are probably only comparable to that of the open
procedure.45,46 A learning curve exists for such complicated
procedures,38,47 and for most series, the full technical
potential may not have been realized.
The place of MIS esophagectomy remains controversial
and is evolving. What is certain is that, with the complexity,
these techniques should be investigated in centers experi-
enced with open method of esophagectomy.
The tumor resection phase of an esophagectomy must be
carried out with care; direct damage to important structures
such as the tracheo-bronchial tree or aorta will have
disastrous immediate consequences, while injuring the
thoracic duct will lead to chylothorax48 or recurrent
laryngeal nerves predisposing patients to aspiration and
pneumonia after surgery.
Recovery from esophagectomy depends to a large extent
on the reconstructive phase. The most common surgical
complication after esophagectomy is still anastomotic leak
and can reach 30%,49 although in experienced centers, leak
rates of below 5% can be achieved. Most leaks are probably
related to technical faults,11,50 such as tension between the
conduit and the esophageal stump, ischemia of the conduit
because of rough handling and poor preparation, and
suboptimal anastomotic technique. The intrinsic vascular
perfusion of the stomach can be enhanced by certain
methods, such as “ischemic pre-conditioning,” whereby
partial mobilization of the gastric conduit is followed by a
second-stage anastomosis later. The perfusion of the
stomach could be shown to improve in the interim period.51
Although an interesting concept and potentially useful,
existing wide range of leak rates (from 2–3% to 30%)
suggest much improvement could be made by other means,
even without ischemic conditioning. It would perhaps be
ideal if one could identify the right patients on whom to
perform ischemic conditioning, so that such elaborate
preparation can be selectively applied.
The actual method of anastomosis is less important than
its proper application. Stapled anastomosis is popular for
intrathoracic anastomosis, while the hand-sewn technique is
preferred in the neck. There is no evidence from random-
ized trials that leak rates differ between stapled and hand-
sewn anastomoses, but the circular stapler may give rise to
more strictures.52 The linear stapler has also been advocated
in the neck. One group reduced their cervical leak rate from
10–15% using a hand-sewn technique to 2.7% using linear
staples with a side-to-side anastomosis.53 With experience,
however, the hand-sewn method is as safe, if not more so,
and certainly less expensive. Leak rate was 3% in our
patients who had an intrathoracic anastomosis, 35% of
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whom died, resulting in an overall leak-related morality of
1% out of all patients who had esophagectomy.50,54
The route of reconstruction is in part related to the surgical
approach for resection. When a cervical anastomosis is
chosen, a choice exists for placing the conduit in the
orthotopic, retrosternal, or subcutaneous route. The subcu-
taneous route is rarely used because it is cosmetically
unsightly. The retrosternal route has variably been shown
to be associated with increased or similar cardiopulmonary
morbidity and mortality rates.55–57 The retrosternal route is
2–3 cm longer compared to the orthotopic route58 but is
rarely of relevance because the esophageal replacement
conduit is usually of sufficient length. Some suggest that
the tight space at the thoracic inlet in the neck could cause
potential constriction on the conduit and recommend partial
manubrium, clavicular head, and first rib resection,59
although the author has found this unnecessary.
Technical variables play an important role in the genesis
of postoperative complications. Complications, such as
anastomotic leaks (largely technique-related) and recurrent
laryngeal nerve injury, for instance, are related to higher
incidences of postoperative pulmonary morbidities. At the
author’s center, pulmonary complications occurred in 10%
of patients without technical complications and in 38% of
patients who developed such morbidities; mortality rates
were 3.3% and 9.2%, respectively.60 Multivariate analyses
also demonstrated that a long operating time was related to
pulmonary complications, and increasing intraoperative
blood loss was related to postoperative mortality.61 In
sum, the meticulous and expeditious execution of an
esophagectomy and its subsequent reconstruction is of
paramount importance in lessening complication and
mortality rates.
Perioperative Care
With adequate preoperative workup, serious cardiac events
like myocardial infarction should be rare. Pulmonary
complications remain the most common and serious
postoperative morbidity. Most report a respiratory morbid-
ity rate of about 20%.10 Pneumonia and respiratory failure
occur in 15.9% of our patients and are responsible for 55%
of hospital deaths. Predictive factors include advanced age,
supracarinal tumor location, and lengthened operating time.
The increased chance of pulmonary complications associ-
ated with supracarinal tumors is in part related to the
prevalence of recurrent laryngeal nerve injury, which
reduces the effectiveness of glottic closure on coughing,
diminishes airway protection, and predisposes to aspiration.
Long-term quality of life is also impaired.62 Neoadjuvant
therapy did not lead to increased morbidity.61 Measures to
improve respiratory outcome include cessation of smoking
preoperatively, chest physiotherapy, avoidance of recurrent
laryngeal nerve injury, cautious fluid administration to
avoid fluid overload, use of smaller chest tube,63 early
ambulation, regular bronchoscopy, and early tracheostomy
to provide easy access should there be sputum retention
despite regular bronchoscopic clearance.64 Epidural anal-
gesia is invaluable in postoperative pain relief and should
be the standard of care after esophagectomy.65 In a
retrospective study at the author’s unit, the use of epidural
analgesia led to a reduction of major pulmonary complica-
tions from 22% to 13%.65
As discussed in the previous section, anastomotic leak
remains one of the most common and deleterious compli-
cations after esophagectomy. Early detection of anastomotic
leaks is important so that timely intervention can be
instituted; sometimes a high index of suspicion is important
when other seemingly unrelated complications develop,
such as atrial fibrillation.66 Atrial arrhythmia is common,
affecting about 20% of patients. In itself, atrial fibrillation is
benign; rather, it serves as a marker for more serious
underlying pulmonary and septic surgical complications.66
Occurrence of atrial arrhythmia should prompt thorough
search for a more ominous underlying cause. In 1946, in
the article published by Ivor Lewis on esophagectomy, he
commented on the postoperative course of one patient: “On
the third day arrhythmia of the heart was present…. In the
next two days his respiration increased, moist sounds
developed at the bases, and he died six days after the
operation.” He further wrote: “I now think this case might
have been saved by timely and repeated bronchoscopic
suction. The cardiac arrhythmia… probably had little to do
wit his death.”67 Thus, the significance of atrial arrhythmia
as a “complication marker” has long been recognized.
Treatment principles dictate adequate drainage, whether by
radiological, endoscopic, or surgical means. Recent use of a
removable plastic stent in sealing anstomotic leaks holds
promise as a “minimally invasive method” of leak
management.68 Maintenance of nutritional status is impor-
tant, preferably via the enteral route, either by a fine-bore
nasoduodenal tube placed endoscopically or by feeding
jejunostomy. Improvements in the management of leaks
have led to reduction in leak-related mortality. At the
author’s unit, anastomotic leak rate was 16% in the 1960s
to 1970s, 61% of whom died, resulting in a leak-related
mortality of 9.8%.54 In the 1980s, leak rate was 3.5%, of
whom 35% died, a leak-related mortality of 1.2%,50 while
in the late 1990s, leak occurred in 3.2% of patients, and
none died as a result.69
Other surgical complications like chylothorax and
herniation of bowel through the diaphragmatic hiatus are
rare but should be recognized early, and both are corrected
by surgical re-exploration. Early exploration is more likely
to be successful than expectant treatment.70
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Summary
In summary, achieving esophagectomy without mortality
depends on realistic patient selection, versatility in the
choice of surgical procedure, its meticulous and expeditious
execution, vigilant and proactive postoperative care, timely
and aggressive intervention, and most of all, multidisci-
plinary team work involving surgeons, anesthesiologists,
intensivists, and other health care workers. An obvious
volume–outcome relationship exists,8,71 but it is the
dedicated care of individuals which matters most.
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